4th Quarter - Report

OGR for TAKEDA PHARMACEUTICALS AMERICA INC

Firm
OGR
Client
Income
$40,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues related to Medicare Part D and Medicaid.

LobbyistCovered position, as disclosed
DEAN AGUILLEN —
MOSES MERCADO —
GORDON TAYLOR —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Issues related to the implementation of the Patient Protection and Affordable Care Act (Public Law No: 111-148), implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) of 2012 (Public Law No: 112-144), the pharmaceutical industry, diabetes care, obesity and mental health.

LobbyistCovered position, as disclosed
DEAN AGUILLEN —
MOSES MERCADO —
GORDON TAYLOR —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.